Bansal Pharma Limited - pharma in Thane, Maharashtra, India. FY 2026 financials and compliance.
CIN U24200MH1997PLC110599 Incorporated 11 September 1997 ROC Mumbai HQ Thane, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹64,110
▼ 71.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹2.78 Cr
Company age
29 yrs
Est. 1997
Last financials
Mar 2025
Balance sheet date

About Bansal Pharma Limited

Data last updated: 06 March 2026

Bansal Pharma Limited is a public limited company based in Thane, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 11 September 1997, the company has been in operation for over 29 years.

Registered with ROC Mumbai under CIN U24200MH1997PLC110599.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sajankumar Rameshwarlal Bajaj and Anil Champalal Jain.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 606 Bhoomi Velocity Infotech Park, Thane, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹64,110, a decline of 71% compared to the previous year.

As per MCA filings, the company has satisfied charges of ₹2.78 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Bansal Pharma Limited
CIN U24200MH1997PLC110599
Registration Number 110599
Incorporation Date 11 September 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    602 – 606 Bhoomi Velocity Infotech Park Plot No.B – 39 39A 39A/1 Rd No.23 Wagle In, D. Estate, Thane, Maharashtra, India – 400604
  • Industry
    Pharma, Drug Formulation & Development
Company report
Bansal Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Bansal Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Bansal Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Bansal Pharma Limited

Bansal Pharma Limited is audited by PARESH RAKESH & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
PARESH RAKESH & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Bansal Pharma Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Bansal Pharma Limited

Bansal Pharma Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sajankumar Rameshwarlal Bajaj Director 01 Apr 1998 28 Years 4 Months Current
Anil Champalal Jain Director 31 Jul 1999 27 Years 0 Months Current
Namrata Sajankumar Bajaj Director 01 Apr 2025 1 Years 4 Months Current

Financials of Bansal Pharma Limited FY 2025 filings available

Bansal Pharma Limited reported revenue of ₹64,110 (down 71.00% YoY) for FY 2024.

Revenue · FY 2024
₹64,110 ▼ 71.00%
Premium access

Ten-year financial statements for Bansal Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Bansal Pharma Limited

Premium access

Shareholding and ownership data for Bansal Pharma Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Bansal Pharma Limited

Open charges
₹0
Satisfied charges
₹2.78 Cr
Breakdown by lending institutions
Corporation Bank₹2.00 Cr
The Saraswat Co-Operative Bank Ltd₹0.78 Cr
Latest charge details
DateLenderAmountStatus
20 Feb 2004 The Saraswat Co-Operative Bank Ltd ₹75 Lakh Satisfied
04 Nov 1999 The Saraswat Co-Operative Bank Ltd ₹3.3 Lakh Satisfied
23 Aug 1999 Corporation Bank ₹1 Cr Satisfied
23 Aug 1999 Corporation Bank ₹1 Cr Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Bansal Pharma Limited

View historical data on people associated with Bansal Pharma Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Bansal Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Bansal Pharma Limited

Premium access

GST registrations and filing compliance for Bansal Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Bansal Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Bansal Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bansal Pharma Limited

Premium access

MSME payment history for Bansal Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bansal Pharma Limited

Premium access

Corporate group structure for Bansal Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bansal Pharma Limited

Premium access

MCA filings and documents for Bansal Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Bansal Pharma Limited

Activity
30 Sep 2025
Bansal Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Directors
01 Apr 2025
Namrata Sajankumar Bajaj was appointed as a Director on 01 Apr 2025 & has been associated with this company since 1 year 4 months.
Activity
31 Mar 2025
Bansal Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
31 Aug 2007
A charge registered on 23 Aug 1999 via Charge ID 90142508 with Corporation Bank was fully satisfied on 31 Aug 2007.
Charges
31 Aug 2007
A charge registered on 23 Aug 1999 via Charge ID 90147332 with Corporation Bank was fully satisfied on 31 Aug 2007.
Charges
20 Jul 2007
A charge registered on 20 Feb 2004 via Charge ID 90148579 with The Saraswat Co-Operative Bank Ltd was fully satisfied on 20 Jul 2007.

Frequently Asked Questions about Bansal Pharma Limited

Bansal Pharma Limited is an active public limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 11 September 1997 (29+ years old) and is registered under CIN U24200MH1997PLC110599.

Bansal Pharma Limited reported revenue of ₹64,110 for FY 2024 (down 71.00% YoY).

The current directors of Bansal Pharma Limited are:

The primary industry of Bansal Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Bansal Pharma Limited can be reached at the registered office: 602 – 606 Bhoomi Velocity Infotech Park Plot No.B – 39 39A 39A1 Rd No.23 Wagle In, D. Estate, Thane, Maharashtra, India – 400604.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available